Companies in #Metabolic Disorders (obesity)
Found 1 company operating in this sector.
BioRestorative Therapies is a Melville, New York-based regenerative-medicine company developing cell and tissue therapies from adult stem cells, focused on disc/spine disease and metabolic disorders. Its lead candidate BRTX-100 is an autologous cultured mesenchymal stem-cell therapy for the non-surgical treatment of painful lumbosacral disc disorders, and ThermoStem targets obesity and metabolic disease using brown-adipose-derived stem cells; the company also runs a commercial biocosmeceutical platform and an investigational curved-needle delivery device. Formerly Stem Cell Assurance, the company renamed in August 2011 and in September 2026 announced a 1-for-20 reverse stock split to regain Nasdaq bid-price compliance.